Join Index
For Startups
For Investors
For Brands
For Analysts
Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Expert
Innovation Services
About Index
Index
By TNW
Log in
Register
Trevi Therapeutics
3001
Trevi Therapeutics
Technology
Biotechnology
Trevi Therapeutics is a drug development company founded in 2011 focused on developing Nalbuphine ER for the severe chronic itching condition known as pruritus.
Suggest edits
Founded
2011
Raised
$98.1M
Follow us
Companies in the same industry
Meissa Vaccines
XW Laboratories Inc.
ViraCyte
Pherecydes Pharma
BridgeBio
Enlivex Therapeutics
Impact Biomedicines
Clora
PyroDex
Aenitis Technologies
Alexa global traffic share
